Porcine Torovirus
LEVELS: Highly unlikely; No human illness; Already in the herd; Reference or research laboratory required; Negligible; Negligible; Little; Available, or not needed
| Register id | porcine_torovirus |
| Type | virus |
| Scientific name | Porcine torovirus |
| NCBI taxid | 237020 |
| Evidence | 2 document(s) |
| Assigned | 2026-09-06, against criteria version 093366e352a2 |
Overview
Porcine torovirus is one of several viruses on this register that pigs carry almost universally without anyone being able to show that it does harm. Seroprevalence runs at 81-100% in adults and nursing piglets, half to three-quarters of subclinically infected weaned pigs shed it, and studies from Europe, North America and South Africa describe it as endemic and usually silent — one survey found it on all fourteen farms tested, with every sow and pig seropositive on three of them. The link between the virus and enteric disease is unclear, and there are no reports confirming that it causes gut lesions at all; where it is found alongside diarrhoea it is usually alongside other agents too. Work on it is hampered by the fact that nobody has managed to grow it in cell culture, so serology has relied on cross-reaction with an equine torovirus and on research ELISAs, and detection on RT-PCR and electron microscopy. No human infection is described.
C1 Zoonotic potential
Likelihood of transmission from pigs to humans
Highly unlikely: Human infection with the agent has never been reported, or has been reported but is not attributed to pig or pork exposure
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c1l1, no evidence of zoonotic transmission from pigs"
Basis. Section 41.7 is the only section in chapter 41 whose opening heading omits "Public Health" -- it reads "Relevance and Etiology" where 41.1, 41.2, 41.3, 41.4 and 41.6 all read "Relevance, Etiology, and Public Health". No human infection is mentioned anywhere in the section. shic_ptov: "The zoonotic potential of porcine ToV is unclear. Early serological studies of farmworkers and veterinarians have not revealed a detectable antibody response against bovine and equine toroviruses."
How this level was decided
INFERRED from a structured silence that is unusually legible here: the chapter uses a standard heading that names public health for every other agent in it, and drops that word for this one. Toroviruses are otherwise known from cattle and horses rather than people. Level 1. Level 1 confirmed. Occupationally exposed people were looked at specifically and no antibody response was found -- an absence from a study that went looking, which is better evidence than silence.
C2 Zoonotic impact
Severity of human illness caused by the agent
No human illness: Agent does not cause illness in people
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c2l1, no evidence of human disease"
Basis. No human disease is described in ch41 41.7. shic_ptov: "Early serological studies of farmworkers and veterinarians have not revealed a detectable antibody response."
How this level was decided
INFERRED, on the same silence. C2 scores level 1 whenever the agent does not cause disease in people. Level 1 confirmed.
C3 Herd introduction risk
Effort required to keep the agent out of the herd
Already in the herd: Present in most herds, or carried by pigs themselves, so there is no introduction event to prevent
Basis. ch41 41.7.1: "Subsequent studies revealed a high seroprevalence (81-100%) in adults or young nursing piglets and high detection rates (50-75%) among subclinically infected weaned pigs." "Latter reports from Europe, North America, and South Africa suggested that PToV was endemic and often subclinical." 41.7.2: "PToVs were endemic in 14 farms tested", with 100% of sows, nursing and older pigs seropositive on three Spanish farms. shic_ptov: "Porcine ToV seems to be widespread in the global swine population." "The only porcine ToV strain isolated in the United States (PToV-NPL/2013)..." "Adults may be chronically infected, acting as reservoir hosts." "Rapid spread of porcine ToV between facilities seems to coincide with the practice of moving and regrouping weaned pigs."
How this level was decided
Seroprevalence of 81 to 100% across every herd surveyed on three continents, with infection cycling after weaning as maternal antibody declines. Carried by the pigs themselves, so there is no introduction event to prevent. Level 1. Level 1 confirmed. Present in US pigs, widespread globally, with chronically infected adults acting as reservoirs inside the herd. Note the factsheet says US prevalence is unknown, which limits how strong the support can be, but presence is established.
C4 Detection difficulty
Difficulty of recognizing and confirming infection
Reference or research laboratory required: A validated assay exists, but only at a national reference or research laboratory rather than at local or regional level
Basis. ch41 41.7.3: "Methods to propagate PToVs in cell culture have not been described." Serological work has used "a cell culture-adapted equine ToV" for cross-reactive antibodies, plus research ELISAs against the PToV N protein and the spike subunit, where "in most, but not all cases, there was a good correlation between ELISA and VN tests". Detection has used immunoelectron microscopy and RT-PCR from individual publications. shic_ptov: "Porcine ToV is not cultivatable." "Immuno-electron microscopy (IEM) has been used to detect antibody-aggregated particles in feces and differentiate ToV from other coronaviruses." "Conventional and real-time reverse transcription polymerase chain reaction (RT-PCR) assays have been developed." "Until the virus can be grown in culture, epidemiological studies can help increase understanding."
How this level was decided
Level 3. The virus has never been cultured, the serology leans on a heterologous equine antigen with acknowledged discrepancies, and the molecular assays are research descriptions. Nothing here is offered as a service. Not level 4, because the RT-PCR assays target conserved regions and have been used across multiple independent studies rather than being a single unevaluated primer set. Level 3 confirmed, and the reason is now explicit: the virus cannot be cultured at all. RT-PCR exists so this is not level 4, but the methods that remain -- PCR and immuno-electron microscopy -- are research-laboratory work.
C5 Production cost
Financial impact on the infected farm's cost of production
Negligible: No measurable effect on cost of production
Basis. ch41 41.7.1: "the link between PToV and enteric disease is unclear, and there are no reports confirming PToV pathogenicity or gut lesions." Detection rates of 50-75% among "subclinically infected weaned pigs". "In China, coinfections with PToV and other enteric pathogens appeared to be common in pigs." shic_ptov: "Infection with porcine ToV is generally subclinical; however, associated signs have included diarrhea, anorexia, dehydration, lethargy, depression."
How this level was decided
The chapter states it directly: no reports confirm pathogenicity or gut lesions, and the link to enteric disease is unclear. High detection rates in pigs described as subclinically infected, and where it is found with diarrhoea it is usually alongside other enteric pathogens. Level 1. Scored rather than left unassessed because the chapter addresses causation and reports it unconfirmed, which is evidence. Level 1 confirmed.
C6 Market impact
Duration of material disruption to pork and pig markets
Negligible: Little or no material disruption to supply or demand when disease occurs on one or more farms
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c6l1, diagnosis would have no effect on markets"
Basis. Section 41.7 records no trade measure, movement control or consumer response. PToV is endemic on three continents with seroprevalence up to 100%.
How this level was decided
INFERRED. An endemic subclinical enteric virus with no confirmed pathogenicity has no route to pork supply or demand. Level 1. Unchanged.
C7 Treatment potential
Potential for treatment to improve outcomes
Little: Effective pathogen-directed treatment is available and works, or animals recover acceptably without it
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c7l1, no economic or clinical imperative to develop a treatment"
Basis. No antiviral is described in ch41 41.7. 41.7.4 addresses control entirely through management: "management practices applicable to control of other enteric CoV infections should be implemented".
How this level was decided
INFERRED. No pathogen-directed treatment exists, and with pathogenicity unconfirmed there is no established outcome for one to improve. Second clause of level 1. Unchanged.
C8 Vaccine availability
Availability of effective vaccines or bacterins
Available, or not needed: Effective vaccines are widely available in the US or secured for national outbreak response, or the disease does not clinically or economically justify vaccinating
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c8l1, no economic or clinical imperative to develop a vaccine"
Basis. No vaccine is described in ch41 41.7. Control rests on management of transport and mixing stress. shic_ptov: "There is no vaccine for porcine ToV."
How this level was decided
INFERRED. No vaccine exists and none is warranted for an agent whose pathogenicity the chapter says is unconfirmed. Level 1 on the second clause. Level 1 held -- generally subclinical infection, no imperative.
Levels and evidence are generated from data/assignments/porcine_torovirus.yml; the overview is authored in data/overviews/porcine_torovirus.md. Do not hand-edit this page — corrections go in data/assignments/CORRECTIONS.yml.
Quoted material marked Basis is from Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, eds. Diseases of Swine, 12th edition. Hoboken: Wiley Blackwell, 2025 — except where another source is named in the quotation itself.